Skip to main content
Full access
Letter to the Editor
Published Online: 1 September 2004

Religion, Spirituality, and Mysticism

Publication: American Journal of Psychiatry
To the Editor: In regard to the article by Jacqueline Borg, Psychol., M.Sc., et al. (1), we were intrigued by the potential association between the serotonin system and the character trait of “self-transcendence.” However, we urge caution in interpreting these results as evidence of a biological basis for religion/spirituality. A careful definition of terms is required to avoid confusion.
“Spirituality” is a relatively new term that refers to the nearly universal human search for meaning, often involving some sense of transcendence. Some suggest that spirituality is a broader concept than religion and is therefore more appropriate for pluralistic contexts (2). However, it is not clear that spirituality actually describes a more universal phenomenon (3). In fact, the concrete and individualized manifestations of “spiritualities” tend to function not as universals but precisely the opposite: unique religions with only one member (4).
On the other hand, “religion” refers to a particular tradition, practice, or community that shapes a comprehensive world-view sufficient to interpret all of human experience within a specific cultural context (3). Within any religious tradition such as Catholicism, there are many practices that may be considered faithful and normative, such as Benedictine monasticism, “third-order” Franciscan spirituality, or the prayer of the Rosary. Of all the practices of spirituality, a small subset might be called “mystical” or marked by visions, “revelations,” or losing the sense of oneself.
Although we doubt a direct correspondence, such mystical experiences may appear similar to the auditory and visual hallucinations induced by psychotropic drugs, such as LSD. Some aspect of such mysticism may be mediated by the serotonergic system. However, Dr. Borg et al. used religion and spirituality interchangeably, and they reduced religion/spirituality to mere mystical experience. This reduction is misguided and potentially confusing. Many faithful religious practices have no mystical component, and in fact, several religious traditions specifically reject the type of mystical experience addressed in this article (5).
Therefore, we suggest that the variability in serotonin may not be best understood as a marker for religiousness, per se, but as a marker for a more general character trait found in both religious and nonreligious people. It would be interesting to repeat a similar study within two populations of religious and secular subjects. We suspect that within both populations, a subset might have lower binding potentials that would correlate not only with “spiritual acceptance” but also with the metrics of mystical experience and perhaps recreational drug use. Finally, given the hypothesis that self-transcendence is environmentally influenced by the differences between Swedish and American cultures, it would be interesting to further test this hypothesis by comparing the results in Sweden and the United States with a population drawn more from the openly mystical contexts found in some African or aboriginal cultures.

References

1.
Borg J, Andrée B, Söderström H, Farde L: The serotonin system and spiritual experiences. Am J Psychiatry 2003; 160:1965–1969
2.
Fetzer Institute/NIA Working Group: Multidimensional Measurement of Religiousness/Spirituality for Use in Health Research. Kalamazoo, Mich, John E Fetzer Institute, 1999
3.
Hall DE, Koenig HG, Meador KG: Conceptualizing “religion”: how language shapes and constrains knowledge in the study of religion and health. Perspect Biol Med 2004; 47:386–401
4.
Bellah R, Madsen R, Sullivan W, Swidler A, Tipton S: Habits of the Heart. New York, Harper & Row, 1985

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1720 - 1721
PubMed: 15337676

History

Published online: 1 September 2004
Published in print: September 2004

Authors

Affiliations

DANIEL E. HALL, M.D., M.Div.
ANA MARIA CATANZARO, Ph.D., R.N.
M. OJINGA HARRISON, M.D.
HAROLD G. KOENIG, M.D.
Durham, N.C.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share